Carrie Wagner

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

Bernie Scallon, Ann Cai, Nancy Solowski et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 667 citations

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Stephen B. Hanauer, Carrie Wagner, Mohan Bala et al. · Clinical Gastroenterology and Hepatology · 2004 · 606 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +11

The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trial

E. William St. Clair, Carrie Wagner, Adedigbo A. Fasanmade et al. · Arthritis & Rheumatism · 2002 · 421 citations

Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study

Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos et al. · The Lancet · 2018 · 317 citations

Rheumatology, Il-23 Inhibitor, Autoimmune Disease +13

Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo‐controlled study of infliximab therapy in early rheumatoid arthritis

Peter C. Taylor, A Steuer, James V. Gruber et al. · Arthritis & Rheumatism · 2004 · 313 citations